Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of adjunctive brivaracetam tablets for focal seizures
CTR20240432Phase 3Active
- Sponsor
- Chengdu Aobang Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, Focal Onset Epilepsy, Focal onset seizure, sponsored by Chengdu Aobang Pharmaceutical. Started Apr 2024; status: active.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on CTR20240432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240432.